Cantor Fitzgerald Initiates $TEM at Overweight With $80 Price Target

Cantor Fitzgerald has initiated coverage of Tempus AI ($TEM) with an Overweight rating and an $80 price target.
The firm argues that the market is mispricing Tempus AI’s Data & Applications segment by treating it like a traditional life sciences data vendor, despite the business boasting growth and margin profiles that more closely resemble a scalable platform model.
Cantor Fitzgerald also pointed to further potential upside driven by biopharma R&D expansion, broader provider adoption, and five underappreciated growth levers.